We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NABL:NYSEN-able, Inc. Analysis

Data as of 2026-05-23 - not real-time

$3.66

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Price action is currently at $3.66, well below the 20‑day SMA of $4.43, the 50‑day SMA of $4.69, and the 200‑day SMA of $6.52, signaling a bearish trend. The RSI of 33.9 suggests the stock is approaching oversold territory, while the MACD line remains bearish at –0.40 below its signal. Support sits at $3.24 with resistance near $5.63, and volatility is elevated at over 80% annualized, though beta is modest at 0.76, indicating limited market‑wide swings. Volume is increasing, providing some liquidity support despite the downtrend.
Fundamentally, N‑able posted $527 M in revenue with 13% YoY growth, an impressive 80% gross margin and a 9.8% operating margin, though profit margin remains slightly negative. Forward EPS of $0.48 and a forward P/E of 7.6 contrast sharply with the industry average P/E of 39.5, while the price‑to‑book ratio of 0.86 and a DCF‑derived fair value of $7.99 imply roughly 87% upside. Cash on hand ($118 M) offsets a sizable debt load, and the recent Q1 ARR increase of 8% underscores growing demand for its cybersecurity and endpoint‑management suite. Analyst consensus is a “buy,” reflecting the blend of strong growth metrics and attractive valuation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • RSI near oversold levels indicating potential bounce
  • Support at $3.24 providing downside cushion
  • Increasing volume signaling renewed buyer interest

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • 13% revenue growth and expanding ARR
  • Undervaluation versus industry P/E and DCF fair value
  • Strong gross margin and improving operating leverage

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Secular demand for cybersecurity and data protection services
  • Recurring revenue model with high customer retention
  • Potential for debt reduction as free cash flow remains robust

Key Metrics & Analysis

Financial Health

Revenue Growth13.10%
Profit Margin-1.99%
P/E Ratio7.6
ROE-1.33%
ROA2.01%
Debt/Equity54.54
P/B Ratio0.9
Op. Cash Flow$91.0M
Free Cash Flow$81.1M
Industry P/E39.5

Technical Analysis

TrendBearish
RSI33.9
Support$3.24
Resistance$5.63
MA 20$4.43
MA 50$4.69
MA 200$6.52
MACDBearish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Fair Value$7.99
Target Price$6.85
Upside/Downside87.16%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.76
Volatility80.56%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.